StratifiCare warmly welcomes Jennifer Lau to join the team as Chief Marketing Officer.
Jennifer has more than 20 years of B2B/B2C working experience in pharmaceutical APIs, CDMO and biotech spaces for Asia Pacific markets, with strong track record in business development and strategic partnership with key customers & government authorities. She had taken leadership and strategic positions in global multinational companies and start-up companies, and was the Vice President, Asia at Seqens Asia Pacific Limited. She had managed numerous projects on M&A deals, due diligence, post-merger integration, greenfield project and digital transformation projects. Jennifer graduated with an MBA from the University of Hull in UK, and a BSc in Chemistry from Imperial College London.
“We are honoured and privileged to have Jennifer join the team. Jennifer has been one of the earliest angel supporters of StratifiCare. We share StratifiCare’s vision of empowering personalized medicine for tomorrow, thereby saving lives and bringing impact to patients and their families. We look forward to tap into Jennifer’s in-depth commercial experience to bring our products to patients who need them the most,” said Dr Anthony Chua, Cofounder and CEO of StratifiCare.